CC

Cheryl Clarkson

North America, Massachusetts, United States, Boston

Description

Cheryl Clarkson

Investor Profile

Cheryl Clarkson has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Clinical Trials, Health Care.

Stage Focus

  • Convertible Note (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Health Care
  • Hospital
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cheryl Clarkson frequently co-invest with?

Red Cedar Ventures
North America, Michigan, United States, East Lansing
Co-Investments: 1
Michigan Rise
North America, Michigan, United States, East Lansing
Co-Investments: 1
Blue Water Angels
North America, Michigan, United States, Midland
Co-Investments: 1
UO
North America, Michigan, United States, Ann Arbor
Co-Investments: 1

Which angels does Cheryl Clarkson often collaborate with?

Shared Deals: 1

What are some of recent deals done by Cheryl Clarkson?

GreenMark Biomedical

East Lansing, Michigan, United States

GreenMark is a healthcare company providing health-based benefits using nanoparticles.

BiotechnologyClinical TrialsHealth CareHospitalMedical Device
Convertible NoteJan 26, 2022
Amount Raised: $830,000